“A Prospective, Randomized and Double Blind Once-Monthly Oral Ibandronate and Risedronate in Post-Menopausal Osteoporosis Leprosy Patients”. International Journal of Biomedical and Advance Research 8, no. 11 (November 30, 2017): 407–415. Accessed March 11, 2026. https://ssjournals.co.in/index.php/ijbar/article/view/4474.